Description
Controloc (Pantoprazole) Tablets 40 mg. №14
Composition
Active ingredient: Pantoprazole 40 mg.
Mechanism of Action
Pantoprazole, a proton pump inhibitor, reduces gastric acid secretion by irreversibly binding to the H+/K+ ATPase enzyme system at the secretory surface of the gastric parietal cell.
Pharmacological Properties
Pantoprazole exhibits a high selectivity and specificity for the proton pump in the gastric parietal cell. It provides effective inhibition of acid secretion with a prolonged duration of action.
Indications for Use
- Treatment of gastroesophageal reflux disease (GERD)
- Healing of erosive esophagitis
- Maintenance of healed erosive esophagitis
Contraindications
Contraindications: Avoid using Controloc if there is a known hypersensitivity to pantoprazole or any other components of the formulation.
Side Effects
Possible side effects of Controloc may include headache, diarrhea, abdominal pain, and nausea. If severe adverse reactions occur, discontinue use and seek medical advice promptly.
Usage Instructions
Dosage: The recommended dose is 40 mg once daily for up to 8 weeks. Swallow the tablet whole with water before a meal. Do not crush or chew the tablet.
Benefits Compared to Analogues
Controloc, with pantoprazole as the active ingredient, offers effective and long-lasting reduction of gastric acid secretion, making it a preferred choice for acid-related disorders compared to other proton pump inhibitors.
Suitable Patient Groups
Controloc is suitable for adults, including the elderly, for the management of acid-related conditions. It is not recommended for children unless specifically prescribed by a healthcare provider.
Storage and Shelf Life
Store Controloc tablets in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use the product after the specified shelf life has passed.
Packaging Description
Controloc tablets are typically packaged in blister packs of 14 tablets each, ensuring convenient and accurate dosing for the prescribed duration of therapy.
Clinical Evidence and Proven Effectiveness
Pantoprazole has been extensively studied and demonstrated efficacy in the treatment of GERD and erosive esophagitis. Clinical trials have shown significant symptom relief and mucosal healing with the use of pantoprazole.
